Interestingly, HMGB1 silencing in PC-3 cells results in dysregulation of genes involved in these processes too, mimicking the dysregulation observed in tumours from patients diagnosed with ovary cystadenocarcinoma and prostate adenocarcinoma (acinar type) with lower levels of HMGB1. This evidence concerns the gene HMGB1 and neoplasm.